Team Members

Prof. Dr. Frank Staal

Prof. Dr. Frank Staal

Chief Scientific Advisor


Prof Dr Frank J.T. Staal obtained his bachelor and master degrees (both cum laude) in Medical Biology at Utrecht University. He obtained his PhD degree (1993) at the Department of Genetics, Stanford University School of Medicine under the supportive guidance of professors Leonard and Leonore Herzenberg where was taught the intricacies of flow cytometry. His thesis dealt with transcriptional regulation of HIV expression in T-lymphocytes and involved many functional flow cytometric assays and cell sorting experiments.

In 1993 he became postdoctoral fellow at the Netherlands Cancer Institute for 2 years, after which he moved back to Utrecht University as fellow of the Royal Academy of Sciences (KNAW) in the laboratory of professor Hans Clevers. In 2000 he was recruited to Erasmus Medical Center (EMC) Rotterdam to start his own laboratory on human T cell development and became assistant professor. In 2004 he was appointed associate professor at EMC and expanded his research to Wnt signaling in blood stem cellsĀ  and T cells, as well as to gene therapy for immune disorders. In 2008 he was recruited to the Leiden University Medical Center (LUMC) and became full professor of Molecular Stem Cell biology.

His current efforts are largely directed at understanding lymphoid differentiation at a genetic and epigenetic level, understanding of thymus biology, bringing stem cell-based gene therapies to the clinic for various immune disorders, red cell disease and lysosomal storage disorders. He is heading several leading EU consortia (RECOMB, SCID-NET) and a national program CURE4LIFE that aims at bringing gene therapies to patients in a sustainable way. He also acts as CSA of Genewity B.V.

Our team members

Arno Bisschop, PhD, MD.
Chief Executive Officer

Prof. Dr. Frank Staal
Chief Scientific Advisor

Prof. Dr. Eric Claassen
Chief Scientific Officer

Max Renes, MPhil, MSc.
Chief Operating Officer

Conny Kruyssen
Chief Financial Officer

Rob Posthumus, LL.M.
Chief Legal Officer

Jelle Feddema, MSc.
Head of Business Dev.

Drs. Johan Renes
Intellectual Property Strategy Advisor

Hadil Es-Sbai, MSc.
Clinical Development Advisor

Linda van de Burgwal, PhD.